IHTC is an Anticoagulation Center of Excellence

11/19/2019

Indianapolis, IN (November 15, 2019) - The Indiana Hemophilia and Thrombosis Center (IHTC) is pleased to announce that it has passed the Anticoagulation Forum’s assessment test and may continue to consider IHTC as an “Anticoagulation Center of Excellence.” This illustrates IHTC's strong commitment to providing the highest level of care to patients taking antithrombotic medications.

The Anticoagulation Centers of Excellence program helps healthcare professionals provide the highest level of care and achieve the best possible outcomes for patients on antithrombotic medications. The program offers a roadmap to consistent, sustainable excellence in five key areas of patient care.  Because it successfully met the rigorous standards in each patient care pillar, IHTC may be considered an Anticoagulation Center of Excellence for 3 years.

The assessment and educational resources on the Anticoagulation Form's site helped IHTC streamline its own operational performance, improve transition of care and knowledge of drug therapy, and enhance patient education while learning more about disease state management. Until now, there has not been a comprehensive standard to define ideal practices for an anticoagulation service or a central place to find relevant resources for our practice. This educational program will have a lasting and profound effect on anticoagulation care for many years to come, and IHTC is proud to be considered an Anticoagulation Center of Excellence.

The Anticoagulation Forum is a multidisciplinary non-profit organization that works to improve the quality of care for patients taking antithrombotic medications. The AC Forum promotes the clinical application of evidence-based practices, and provides education and networking opportunities for healthcare professionals. To learn more about the program visit www.acforum-excellence.org